A5052895134- Acute Lymphoblastic Leukemia research
- Lymphoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- COVID-19 and healthcare impacts
- Tuberculosis Research and Epidemiology
- Radiomics and Machine Learning in Medical Imaging
- COVID-19 Clinical Research Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Heparin-Induced Thrombocytopenia and Thrombosis
- Cytomegalovirus and herpesvirus research
- Biochemical and Molecular Research
- Venous Thromboembolism Diagnosis and Management
- Ovarian cancer diagnosis and treatment
- Platelet Disorders and Treatments
- Sarcoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Ospedale di Belcolle
2024
Sapienza University of Rome
2021-2023
Not available.
Background: Despite that the unfavorable prognostic role of a high Total Metabolic Tumor Volume (TMTV) in Follicular Lymphoma has been demonstrated, SUVmax alone at baseline PET/CT could have different role. Patients and Methods: We performed retrospective observational monocentric cohort study. All patients affected by FL who underwent basal were included. Two subgroups identified compared terms PFS OS: (A) Basal ≤ 6; (B) > 6. Results: Ninety-four included, 34 group A (36.2%) 60 B...
Background: CMV reactivation can occur after immunosuppression, in particular the transplant, but it rarely occurs during chemotherapy for hematologic malignancies. Novel targeted compounds has raised issue of infections. Sporadic case infection have been reported dasatinib treatment ALL. The incidence observed about 10% patients treated frontline with followed by blinatumomab (Foà et al, NEJM 2020). Aims: aim this work was to analyze reactivation/infection, and management outcome either...
Introduction: Follicular Lymphoma (FL) is an indolent disease: despite the efficacy of treatment strategies in inducing remission, high risk patients relapse within two years and others on long term. Despite encouraging studies prognostic role Total Metabolic Tumor Volume (TMTV) SUVmax at baseline PET/CT needs to be better defined. Methods: Retrospective observational monocentric cohort study performed Sapienza University Rome. All affected by FL who underwent a basal staging were included....
Introduction: Positron Emission Tomography/Computed Tomography (PET CT) is crucial in staging and response assessment Hodgkin lymphoma (HL). While early tumor assessed through an interim PET (I-PET) by Deauville 5-point scale (DS), end of treatment (EoT) CT used to evaluate absence or presence metabolic disease, lacking scientific evidence a correlation between specific DS prognosis. Our study aimed analyse EoT demonstrate possible prognostic patient prognosis terms Relapse Free Survival...